Comprehensive Genomic Profiling in GI Cancers: JCO Precision Oncology | August 2026
Introduction:
Comprehensive genomic profiling (CGP) is increasingly used in gastrointestinal cancers to identify actionable molecular alterations and guide precision therapy. However, its real-world value depends not only on detecting a target but also on whether patients can actually access the matched treatment. This study evaluated CGP performance and clinical impact in a large comprehensive cancer center.
Why was this study needed?
CGP can identify therapeutic targets missed by routine molecular testing.
Its real-world technical success and clinical benefit remain uncertain.
Tissue quality can limit successful genomic profiling.
Even when actionable alterations are detected, access to matched therapy remains challenging.
Results:
Among 1,450 samples, approximately 10% failed CGP, predominantly because of inadequate tumor DNA.
Among metastatic patients, 28% had actionable genomic alterations, but only about 16% of these patients received matched targeted therapy.
Patients receiving genomically matched therapy had substantially longer survival (26.4 months) than those with actionable alterations who did not receive matched treatment.
Among untreated patients with actionable alterations, lack of suitable clinical trials or trial ineligibility was a major barrier to precision treatment.
Clinical Impact:
CGP can translate into meaningful clinical benefit in GI oncology—but only when an actionable finding leads to treatment. The study emphasizes early genomic testing at diagnosis of advanced disease, careful tissue selection, multidisciplinary molecular tumor boards, and better access to clinical trials and targeted therapies.
Bottom Line:
Comprehensive genomic profiling identified actionable alterations in more than one-quarter of metastatic GI cancers, and patients who received matched therapy had markedly better survival. The major challenge is no longer simply finding the target—it is ensuring that patients can access the treatment.